Thursday, 17 August 2017

Biologics News

  • Agilent, A*Star, French univ sign biologics MoU

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 27 May, 2013

    Singapore: Agilent Technologies, Glyco-MEV laboratory at the University of Rouen, France, and Bioprocessing Technology Institute (BTI) at the Agency for Science, Technology and Research (A*...Read more

  • Green Cross to expand biologics market in Russia

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 03 Apr, 2015

    Singapore: Korea based biopharmaceutical company, Green Cross, has partnered with Nanolek, a Russian pharmaceutical company, for the commercialisation of Green Cross' biologics in the Russi...Read more

  • Green Cross builds biopharmaceutical facility in Canada

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 05 Jun, 2015

    Singapore: Korea's Green Cross Biotherapeutics has started the construction of its biopharmaceutical facility located on the Montreal Technoparc's Saint-Laurent Campus. The $215 million pr...Read more

  • China Biologic clocks 19% growth in 2014 turnover

    Biologics |  Company results | By BioSpectrum Bureau | 0 Comment | 05 Mar, 2015

    Singapore: China Biologic Products clocked $243.3 million in 2014, marking a jump of 19.6 percent from 2013 that scaled to $203.4 million. Mr David (Xiaoying) Gao, chairman and chief execu...Read more

  • Baxter initiates clinical trial for home hemodialysis system

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 16 Mar, 2016

    Singapore: Baxter International has announced the enrollment of the first patient in a US clinical trial for VIVIA, an investigational home hemodialysis (HD) system being developed by Baxte...Read more

  • Biocon gets DCGI nod for psoriasis drug itolizumab

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 09 Jan, 2013

    Bangalore: Biocon received marketing authorization from the Drugs Controller General of India (DCGI) for its novel biologic itolizumab, which is an anti-CD6 molecule used for the treatment ...Read more

  • Genovate biotech to invest $1bn in China

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 28 Sep, 2015

    Singapore: Genovate Biotechnology, Taiwan based pharmaceutical company, has started the construction of phase I of its Insulin Ecological Industrial Park in Changzhou National Hi-tech Distr...Read more

  • New breakthrough in dementia research

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 18 Sep, 2014

    Singapore: Researchers at the Taipei-based Academia Sinica announced that they have discovered a new molecule that aids in screening, early detection of dementia and other diseases caused b...Read more

  • BioSpectrum announces the hits and misses of 2013

    Biologics |  Analysis | By BioSpectrum Bureau | 0 Comment | 02 Jan, 2014

    Asia attracted a lot of interest from foreign multinational giants in the year 2013. This not only led to the increase in the number of acquisitions and mergers (M&A), it also led to a ...Read more

  • Potential biomarker for cancer diagnosis identified

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 10 Jul, 2013

    Singapore: Scientists studying cancer development have known about micronuclei for some time. These erratic, small extra nuclei, which contain fragments, or whole chromosomes that were not ...Read more

  • World's first IVF born after DNA sequencing

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 09 Jul, 2013

    Singapore: The world's first test tube baby to have undergone an embryo selection using a procedure that can read the entire human genome was born in June. Making the announcement of this ...Read more

  • Merck to market single-use fill solutions with Groninger

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 07 Aug, 2013

    Singapore: Merck Millipore, the Life Science division of Merck has signed a co-marketing agreement with Germany based Groninger, a leading provider of filling and packaging equipment for th...Read more

  • Nuvilex licenses Austrianova's livecell encapsulation technology

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 14 Nov, 2013

    Singapore: Nuvilex, an international biotechnology company providing cell and gene therapy solutions forthe treatment of diseases, has acquired the exclusive worldwide rights to use Singapo...Read more

  • We scaled back operations at our Mumbai R&D unit: Piramal

    Biologics |  Analysis | By Raj Gunashekar | 0 Comment | 29 Apr, 2015

    Singapore: The global CRAMS (Contract Research and Manufacturing Services) segment is becoming intensely competitive. Cost pressures and heightened regulatory intensity pose key challenges ...Read more

  • Bone marrow banking is a possibility in future

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 22 Mar, 2013

    Singapore: More than 50,000 stem cell transplants are performed each year worldwide. A research team led by US-based Weill Cornell Medical College investigators may have solved a major issu...Read more

  • Patrys' cancer diagnostic gets Australian govt grant

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 10 Jul, 2013

    Singapore: Australia based clinical stage biotechnology company Patrys' scientific collaborators at Macquarie University, Sydney, have been awarded a $427,510 Australian government grant to...Read more

  • Scientists unravel proteins that mediates sense of touch

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 04 Dec, 2014

    Singapore: Solving a long standing mystery, the researchers at the Scripps Research Institute have identified a new mechano receptor protein that mediates the sense of touch in animals. The...Read more

  • China develops Ebola diagnostic tests

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 02 Dec, 2014

    Singapore: The China Food and Drug Administration (CFDA) said in a statement that top health authorities had approved three diagnostic test reagents for Ebola, developed by Daan Gene of San...Read more

Orchard Therapeutics appoin...

Survey Box

Does Asia have more to offer to the global 3D cell culture market?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls